|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 362.15 DKK | -1.13% |
|
-0.17% | -49.38% |
| 07-09 | European shares close at four-week high on banks boost; US trade talks in focus | RE |
| 07-08 | European shares rise on energy, healthcare boost; tariff uncertainty lingers | RE |
| Capitalization | 26B 4.08B 3.48B 3.25B 3.02B 5.58B 350B 6.2B 38.9B 14.87B 164B 15.29B 14.97B 601B | P/E ratio 2025 * |
4.71x | P/E ratio 2026 * | 47.3x |
|---|---|---|---|---|---|
| Enterprise value | 14.41B 2.26B 1.93B 1.8B 1.67B 3.09B 194B 3.44B 21.55B 8.24B 90.73B 8.47B 8.3B 333B | EV / Sales 2025 * |
1.72x | EV / Sales 2026 * | 3.29x |
| Free-Float |
99.18% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Zealand Pharma A/S
More recommendations
More press releases
More news
| 1 day | -1.13% | ||
| 1 week | -0.17% | ||
| Current month | +2.11% | ||
| 1 month | -12.81% | ||
| 3 months | -19.83% | ||
| 6 months | -47.96% | ||
| Current year | -49.38% |
| 1 week | 360.5 |  | 379.6 |
| 1 month | 347.6 | | 450.1 |
| Current year | 347.6 | | 808 |
| 1 year | 347.6 | | 967.5 |
| 3 years | 108.4 | | 972 |
| 5 years | 69.55 | | 972 |
| 10 years | 69.55 | | 972 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 30/03/2022 | |
| Director of Finance/CFO | - | 01/11/2022 | |
David M. Kendall
CTO | Chief Tech/Sci/R&D Officer | 63 | 02/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
Kirsten Drejer
BRD | Director/Board Member | 69 | 19/04/2018 |
| Director/Board Member | 66 | 04/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.13% | -0.17% | -60.99% | +229.57% | 4.08B | ||
| -0.06% | +3.05% | +12.57% | +32.08% | 34.39B | ||
| +9.99% | +8.94% | +98.84% | -27.18% | 30.84B | ||
| -0.90% | +2.63% | +32.89% | -32.25% | 27.8B | ||
| +1.57% | +0.39% | +27.99% | +322.28% | 18.65B | ||
| -3.40% | +1.83% | +192.40% | +2,524.95% | 18.57B | ||
| +0.38% | +6.79% | +141.43% | -66.33% | 13.81B | ||
| -0.51% | +4.74% | -24.27% | -45.18% | 13.28B | ||
| +4.42% | +4.60% | +206.61% | +395.60% | 12.94B | ||
| -0.69% | -2.80% | +100.27% | +107.40% | 12.23B | ||
| Average | +0.96% | +1.84% | +72.77% | +344.09% | 18.66B | |
| Weighted average by Cap. | +1.55% | +3.03% | +73.81% | +311.43% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.37B 1.31B 1.12B 1.05B 972M 1.8B 113B 2B 12.53B 4.79B 52.73B 4.92B 4.82B 193B | 4.07B 637M 545M 508M 472M 873M 54.69B 970M 6.08B 2.33B 25.61B 2.39B 2.34B 93.93B |
| Net income | 5.56B 872M 745M 694M 646M 1.19B 74.78B 1.33B 8.32B 3.18B 35.01B 3.27B 3.2B 128B | 327M 51.32M 43.89M 40.88M 38.02M 70.25M 4.4B 78.07M 490M 187M 2.06B 192M 189M 7.56B |
| Net Debt | -11.59B -1.82B -1.55B -1.45B -1.35B -2.49B -156B -2.76B -17.34B -6.63B -73B -6.82B -6.67B -268B | -12.64B -1.98B -1.69B -1.58B -1.47B -2.71B -170B -3.01B -18.91B -7.23B -79.58B -7.43B -7.28B -292B |
More financial data
* Estimated data
Employees
385
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/25 | 362.30 kr | -1.09% | 74,411 |
| 11/07/25 | 366.30 kr | -3.10% | 210,033 |
| 10/07/25 | 378.00 kr | +3.56% | 352,645 |
| 09/07/25 | 365.00 kr | -2.67% | 366,293 |
| 08/07/25 | 375.00 kr | +3.36% | 474,219 |
Delayed Quote Nasdaq Copenhagen, July 14, 2025 at 01:26 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
366.30DKK
Average target price
862.80DKK
Spread / Average Target
+135.54%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZEAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition